In an exclusive conversation, we spoke with renowned bioengineering professor and associate director of the Stanford Institute of Human-Centered AI, Russ Altman, MD, PhD. Altman’s lab focuses on how human genetic variation affects drug response… When Covid-19 took shape, he and his colleagues refocused their mission. While clinical trials can take years, in a matter of weeks Altman and his team identified a drug that could be helpful in the fight against Covid-19, using an approach pioneered by Stanford research scientist Stefano Rensi.
